DE69120452T2 - Verwendung und Verabreichung von Enzymen - Google Patents

Verwendung und Verabreichung von Enzymen

Info

Publication number
DE69120452T2
DE69120452T2 DE69120452T DE69120452T DE69120452T2 DE 69120452 T2 DE69120452 T2 DE 69120452T2 DE 69120452 T DE69120452 T DE 69120452T DE 69120452 T DE69120452 T DE 69120452T DE 69120452 T2 DE69120452 T2 DE 69120452T2
Authority
DE
Germany
Prior art keywords
antibody
enzyme
enzymes
product according
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69120452T
Other languages
German (de)
English (en)
Other versions
DE69120452D1 (de
Inventor
Thomas Stewart Beggs
Paul James Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan Nederland Services BV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909006328A external-priority patent/GB9006328D0/en
Priority claimed from GB909021671A external-priority patent/GB9021671D0/en
Application filed by Unilever NV filed Critical Unilever NV
Application granted granted Critical
Publication of DE69120452D1 publication Critical patent/DE69120452D1/de
Publication of DE69120452T2 publication Critical patent/DE69120452T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6815—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • A61K47/6885—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy the conjugate or the polymer being a starburst, a dendrimer, a cascade
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/94—Involves covalent bonding to the substrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE69120452T 1990-03-21 1991-03-20 Verwendung und Verabreichung von Enzymen Expired - Fee Related DE69120452T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909006328A GB9006328D0 (en) 1990-03-21 1990-03-21 Cell killing
GB909021671A GB9021671D0 (en) 1990-10-05 1990-10-05 Delivery of agents

Publications (2)

Publication Number Publication Date
DE69120452D1 DE69120452D1 (de) 1996-08-01
DE69120452T2 true DE69120452T2 (de) 1996-10-31

Family

ID=26296815

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69120452T Expired - Fee Related DE69120452T2 (de) 1990-03-21 1991-03-20 Verwendung und Verabreichung von Enzymen

Country Status (9)

Country Link
EP (1) EP0450800B1 (OSRAM)
JP (1) JPH04234821A (OSRAM)
AT (1) ATE139704T1 (OSRAM)
AU (1) AU642979B2 (OSRAM)
BR (1) BR9101118A (OSRAM)
CA (1) CA2038577C (OSRAM)
DE (1) DE69120452T2 (OSRAM)
ES (1) ES2088464T3 (OSRAM)
IN (1) IN172886B (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9021671D0 (en) * 1990-10-05 1990-11-21 Unilever Plc Delivery of agents
AU642980B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Ultilization of enzymes
US5486360A (en) * 1993-04-22 1996-01-23 St. Joseph Health Centre Method of treating tumour cells using catalase
JP2000503000A (ja) * 1995-12-21 2000-03-14 クエスト・インターナショナル・ビー・ブイ 粒状組成物
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
US5871714A (en) * 1997-10-16 1999-02-16 Pharmacal Biotechnologies, Inc. Compositions for controlling bacterial colonization
EP1787627A1 (en) 2005-11-17 2007-05-23 3M Innovative Properties Company Anti-microbial dental impression material
BR112013015459B8 (pt) 2010-12-20 2018-06-12 Du Pont método, produto de cuidado oral e composição de geração de perácido
WO2012087966A2 (en) 2010-12-20 2012-06-28 E. I. Du Pont De Nemours And Company Targeted perhydrolases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1433593A (en) * 1972-06-09 1976-04-28 Royal College Of Surgeons Conjugates
US4657853A (en) * 1984-09-14 1987-04-14 E. I. Du Pont De Nemours And Company Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody
DE3786000T3 (de) * 1986-08-18 1997-08-21 Dow Chemical Co Conjugate dichter Sterne.
US4943525A (en) * 1987-11-02 1990-07-24 Bioventures, Inc. Simultaneous immunoassay for the determination of antigens and antibodies
SE461570B (sv) * 1988-06-06 1990-03-05 Rama Bio Link Ab Farmaceutiskt preparat och konjugat av en baktericid och en antikropp
AU4402589A (en) * 1988-09-28 1990-04-18 Ideon Corporation Combination enzyme immunotherapeutics

Also Published As

Publication number Publication date
JPH04234821A (ja) 1992-08-24
AU642979B2 (en) 1993-11-04
AU7299691A (en) 1991-10-03
ATE139704T1 (de) 1996-07-15
ES2088464T3 (es) 1996-08-16
EP0450800B1 (en) 1996-06-26
CA2038577A1 (en) 1991-09-22
DE69120452D1 (de) 1996-08-01
BR9101118A (pt) 1991-11-05
IN172886B (OSRAM) 1993-12-25
EP0450800A1 (en) 1991-10-09
CA2038577C (en) 2001-06-19

Similar Documents

Publication Publication Date Title
DE69119817T2 (de) Verwendung von Enzymen
DE69523440T2 (de) Mundpflegemittel
DE69127334T2 (de) Verabreichung von Mitteln
DE3539202C2 (OSRAM)
DE69332416T2 (de) Stabilisierte enzymatische antimikrobielle zusammensetzungen
EP0404097B1 (de) Bispezifische und oligospezifische, mono- und oligovalente Rezeptoren, ihre Herstellung und Verwendung
DE69110678T2 (de) Prophylaktische und therapeutische anwendungen von peroxidasen.
DE69521158T2 (de) Proteinextrakt aus Cucumis melo mit Antioxydationswirkung und Verfahren zur Herstellung, kosmetische oder pharmazeutische Zubereitung oder Nahrungszubereitung die so ein Extrakt enthält
DE69737532T2 (de) ZUSAMMENSETZUNGEN ZUR KONTROLLE VON ORALEN MIKROBIELLEN OXIDATION-REDUKTION (E h) SPIEGELN
DE69304292T2 (de) Tetracycline inclusive nicht antimicrobiel wirksame, chemisch modifizierte Tetracycline hemmende exzessive Kollagenquervernetzung bei Diabetes
DE69714595T2 (de) Lagenstabile zahnpastazusammensetzung enthaltend casein-glycomakropeptide
DE2545986A1 (de) Kosmetika auf der basis von enzymen
DD209578A5 (de) Verfahren zur herstellung von immunoenzymatischen konjugaten
DE3447343A1 (de) Oral anzuwendendes mittel
DE19735587A1 (de) Peptid mit radioprotektiver Wirkung
DE2723191A1 (de) Kultivierung eines desodorierenden laktobazillusstammes, dessen lagerung sowie eine zusammensetzung, die dessen lebende zellen enthaelt
DE69324046T2 (de) Protein präparate zur verhütung und behandlung van periodontitis und sonstigen bakteriellen erkrankungen der mundhöhle
DE69115104T2 (de) Composition comprising at least two different antibodies or fragments thereof.
DE2917899A1 (de) Lyophilisierte urokinasezubereitung zu injektionszwecken und verfahren zu ihrer herstellung
DE2329253A1 (de) Mundpraeparat
DE69411090T2 (de) Kosmetisches Präparat mit einer Zusammensetzung einer Superoxyd Dismutase und eines Melaninpigmentes
EP0501215B1 (de) Monoklonalantikörper, Linker- und Beta-Glucuronidase enthaltende Fusionsproteine zur Prodrug-Aktivierung, ihre Herstellung und Verwendung
EP0450800B1 (en) Utilization and delivery of enzymes
DE4324859A1 (de) Oral verabreichbare Zusammensetzung zur Behandlung periodontaler Erkrankungen
Sreenivasan et al. Antibacterials as anti-inflammatory agents: Dual action agents for oral health

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: QUEST INTERNATIONAL B.V., NAARDEN, NL

8339 Ceased/non-payment of the annual fee